Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomised, Comparative, Open, Three Armed Parallel Group Study on the Use of Metformin, Repaglinide or the Combination of Both in Type 2 Diabetic Patients After Failure of Dietary Measures

NCT01465152 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01465152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01465152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomised, Comparative, Open, Three Armed Parallel Group Study on the Use of Metformin, Repaglinide or the Combination of Both in Type 2 Diabetic Patients After Failure of Dietary Measures
Lead sponsor
Novo Nordisk A/S
Phase
Phase 4
Overall status
Completed
Start date
March 6, 2002
Completion date
October 21, 2004
Enrollment
182 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2